Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
biotech
4
×
boston blog main
boulder/denver blog main
boulder/denver top stories
clinical trials
4
×
detroit blog main
detroit top stories
gilead sciences
4
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
4
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
cancer
cancer immunotherapy
gene therapy
immunotherapy
multiple myeloma
sanofi
biogen
cell therapy
covid-19
What
bio
roundup
abbvie’s
acquisitions
ahead
american
announced
annual
approval
ash
biofourmis
biogen’s
biopharmaceutical
blood
borne
bucks
cancer
cancers
celebrate
ceo
chance
collabs
companies
conference
convo
corner
covid
daniel
day
days
deal
diego
drug
earlier
failures
forward
gathering
gilead
gilead’s
guide
Language
unset
Current search:
biotech
×
novartis
×
" clinical trials "
×
" seattle top stories "
×
" gilead sciences "
×
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More